SHC1 and breast carcinoma: These data suggest that although reduced pY313-ShcA signalling potentiates IFN-regulated transcriptional responses in breast cancer cells in vitro, it is insufficient to overcome immune suppression in MT/Shc313F/313F tumours in vivo (Fig. 1c,d).